These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 629612)

  • 1. Cholestatic jaundice caused by D-penicillamine.
    Barzilai D; Dickstein G; Enat R; Bassan H; Lichtig C; Gellei B
    Ann Rheum Dis; 1978 Feb; 37(1):98-100. PubMed ID: 629612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal cholestatic hepatitis caused by D-penicillamine.
    Jacobs JW; Van der Weide FR; Kruijsen MW
    Br J Rheumatol; 1994 Aug; 33(8):770-3. PubMed ID: 8055207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestatic jaundice associated with D-penicillamine therapy.
    Gefel D; Harats N; Lijovetsky G; Eliakim M
    Scand J Rheumatol; 1985; 14(3):303-6. PubMed ID: 4048879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of cholestatic hepatitis associated with D-penicillamine therapy for rheumatoid arthritis.
    Devogelaer JP; Huaux JP; Coche E; Rahier J; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(1):35-8. PubMed ID: 3997313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver complications caused by D-penicillamine. Apropos of a case].
    Roux H; Bonnefoy-Cudraz M; Antipoff GM
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):21-3. PubMed ID: 3704507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected adverse reactions of D-penicillamine.
    Stein HB; Chalmers A; Schroeder ML; Dillon A
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis associated with D-penicillamine therapy: case report and review of the literature.
    Seibold JR; Lynch CJ; Medsger TA
    Arthritis Rheum; 1981 Mar; 24(3):554-6. PubMed ID: 7213433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intrahepatic cholestasis following treatment with D-penicillamine and indomethacin].
    Siegmund H
    Med Welt; 1976 Jan; 27(4):172-3. PubMed ID: 1250131
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholestasis associated with d-penicillamine therapy for rheumatoid arthritis.
    McLeod BD; Kinsella TD
    Can Med Assoc J; 1979 Apr; 120(8):965-6. PubMed ID: 436073
    [No Abstract]   [Full Text] [Related]  

  • 10. D-penicillamine-induced acute hypersensitivity pneumonitis and cholestatic hepatitis in a patient with rheumatoid arthritis.
    Kumar A; Bhat A; Gupta DK; Goel A; Malaviya AN
    Clin Exp Rheumatol; 1985; 3(4):337-9. PubMed ID: 4085166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.
    Fishel B; Tishler M; Caspi D; Yaron M
    Ann Rheum Dis; 1989 Jul; 48(7):609-10. PubMed ID: 2774703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-penicillamine induced cholestatic jaundice.
    Choudhuri G; Tandon RK
    J Assoc Physicians India; 1986 Apr; 34(4):299-300. PubMed ID: 3759835
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
    Rosenbaum J; Katz WA; Schumacher HR
    Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholestatic hepatitis caused by D-penicillamine].
    Guerrero Navarro L; Molina Lorente E; Mur Villacampa M; Revillo Pinilla P
    Rev Esp Enferm Apar Dig; 1988 Feb; 73(2):221. PubMed ID: 3375535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
    Wozel G; Julius U
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestatic hepatitis caused by penicillamine.
    Multz CV
    JAMA; 1981 Aug; 246(6):674-5. PubMed ID: 7253120
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis.
    Matsukawa Y; Saito N; Nishinarita S; Horie T; Ryu J
    Clin Rheumatol; 1998; 17(1):73-4. PubMed ID: 9586686
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythema nodosum and cholestatic hepatitis during treatment with D-penicillamine].
    Grauer JL; Fonteille J; Zarski JP; Gintz B; Phelip X; Cabanel G
    Presse Med; 1983 Sep; 12(32):1997. PubMed ID: 6225106
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis.
    Doyle DR; McCurley TL; Sergent JS
    Ann Intern Med; 1983 Mar; 98(3):327-30. PubMed ID: 6830075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.